Silexion Therapeutics Corp (SLXN) stock
SLXNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SLXNW
$1.44−0.21 (-12.73%)
Close on Nov 18, 2026Market cap $868.40KP/E –Yield –
Silexion Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Silexion Therapeutics's total assets was $6.83M at Sep 30, 2026. For fiscal 2025 it was $7.22M, up 152.0% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.22M | +152.0% |
| FY2024 | Dec 31, 2024 | $2.86M | -45.5% |
| FY2023 | Dec 31, 2023 | $5.26M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.83M | -41.2% |
| Q2 FY2026 | Jun 30, 2026 | $4.25M | -26.8% |
| Q1 FY2026 | Mar 31, 2026 | $4.60M | -44.6% |
| Q4 FY2025 | Dec 31, 2025 | $7.22M | +152.0% |
| Q3 FY2025 | Sep 30, 2025 | $11.61M | +276.2% |
| Q2 FY2025 | Jun 30, 2025 | $5.80M | +150.4% |
| Q1 FY2025 | Mar 31, 2025 | $8.31M | +131.7% |
| Q4 FY2024 | Dec 31, 2024 | $2.86M | -45.5% |
| Q3 FY2024 | Sep 30, 2024 | $3.09M | – |
| Q2 FY2024 | Jun 30, 2024 | $2.32M | – |
| Q1 FY2024 | Mar 31, 2024 | $3.59M | – |
| Q4 FY2023 | Dec 31, 2023 | $5.26M | – |
See a number that looks wrong?